【Abstract】ObjectiveTo investigate whether abnormal expression of β-catenin and high expression of c-myc have played a possible role in hilar cholangiocarcinoma carcinogenesis.
MethodsBy using immunohitochemical staining (SP method), the authors detected the expression of β-catenin and c-myc in 42 paraffin-embedded samples of hilar cholangiocarcinoma and 10 benign bile duct disease tissue, and then analyzed the relationship of them with clinical data.
Resultsβ-catenin was normally expressed in 10 benign bile duct disease tissue, while expression of c-myc was negtive. In hilar cholangiocarcinoma tissue, the positive expression rate of β-catenin （71.4%） was significantly correlated to the lymphoid node metastasis of hilar cholangiocarcinoma (χ2=4.75，P＜0.05),but was not statistically correlated to the tumor size，the extent of differentiation and infiltration (χ2=3.35，3.45，4.32，P gt;0.05); the expression rate of c-myc (76.2%) was correlated with the extent of differentiation(χ2=4.87, P＜0.05),but not with the size, infiltration, lymphoid metastasis（χ2= 3.47，4.12，2.76， P gt;0.05). The abnormal expression of β-catenin had relevance to the high expression of c-myc with hilar cholangiocarcinoma （r=0.324,P＜0.01）.
ConclusionThe expression of beta-catenin and c-myc is significantly altered in hilar cholangiocarcinoma, and correlate with biological features of cholangiocarcinoma.The abnormal expression of beta-catenin is one of the mechanisms for the spread of hilar cholangiocarcinoma.
Citation：
ZHENG Qichang,CHEN Haibo,ZUO Keqiang,ZHANG Yong.. Expression of Beta-Catenin in Hilar Cholangiocarcinoma and Relevance to the Expression of c-myc Gene. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2005, 12(1): 67-70. doi:
Copy
Copyright © the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved
| 1. |
Jawhari AU, Farthing MJ, Pignatelli M. The Ecadherin/epidermal growth factor receptor interaction: a hypothesis of reciprocal and reversible control of intercellular adhesion and cell proliferation [Ｊ]. J Pathol， 1999； 187(2)∶155.
|
| 2. |
He TC, Sparks AB, Rago C, et al. Identification of cmyc as a target of the APC pathway [Ｊ]. Science，1998； 281（5）∶ 1509.
|
| 3. |
Jawhari A, Jordan S, Poole S, et al. Abnormal immunoreactivity of the Ecadherincatenin complex in gastric cancer: relationship with patient survival [Ｊ]. Gastroenterology, 1997； 112（4）∶46.
|
| 4. |
Fromowitz FB, Steinbook ML, Lautin EM, et al. ras p21 expression in the progression of breast cancer [Ｊ]. Hum Pathol， 1987； 18(12)∶1268.
|
| 5. |
Tetsu O, McCormick F. betacatebub regulates expression of cyclinD1 in colon carcinoma cells [Ｊ]. Nature， 1999； 398(6726)∶422.
|
| 6. |
Alman BA, Li C, Pajerski ME, et al.Increased betacatenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors) [Ｊ]. Am J Pathol，1997； 151(2)∶329.
|
| 7. |
Kishida S, Yamamoto H,Ikeda S, et al. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of betacatenin [Ｊ]. J Biol Chem, 1998； 273(18)∶10823.
|
| 8. |
臧桐，庄立岩，张志文， 等. β连环蛋白基因在肾癌中的表达及其突变分析 [Ｊ].中华泌尿外科杂志,2000； 21(6)∶328.
|
| 9. |
Ougolkov A, Yamashita K, Bilim V, et al. Abnormal expression of Ecadherin, betacatenin, and cerbB2 in advanced gastric cancer: its association with liver metastasis [Ｊ]. Int J Colorectal Dis， 2003； 18(2)∶160.
|
- 1. Jawhari AU, Farthing MJ, Pignatelli M. The Ecadherin/epidermal growth factor receptor interaction: a hypothesis of reciprocal and reversible control of intercellular adhesion and cell proliferation [Ｊ]. J Pathol， 1999； 187(2)∶155.
- 2. He TC, Sparks AB, Rago C, et al. Identification of cmyc as a target of the APC pathway [Ｊ]. Science，1998； 281（5）∶ 1509.
- 3. Jawhari A, Jordan S, Poole S, et al. Abnormal immunoreactivity of the Ecadherincatenin complex in gastric cancer: relationship with patient survival [Ｊ]. Gastroenterology, 1997； 112（4）∶46.
- 4. Fromowitz FB, Steinbook ML, Lautin EM, et al. ras p21 expression in the progression of breast cancer [Ｊ]. Hum Pathol， 1987； 18(12)∶1268.
- 5. Tetsu O, McCormick F. betacatebub regulates expression of cyclinD1 in colon carcinoma cells [Ｊ]. Nature， 1999； 398(6726)∶422.
- 6. Alman BA, Li C, Pajerski ME, et al.Increased betacatenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors) [Ｊ]. Am J Pathol，1997； 151(2)∶329.
- 7. Kishida S, Yamamoto H,Ikeda S, et al. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of betacatenin [Ｊ]. J Biol Chem, 1998； 273(18)∶10823.
- 8. 臧桐，庄立岩，张志文， 等. β连环蛋白基因在肾癌中的表达及其突变分析 [Ｊ].中华泌尿外科杂志,2000； 21(6)∶328.
- 9. Ougolkov A, Yamashita K, Bilim V, et al. Abnormal expression of Ecadherin, betacatenin, and cerbB2 in advanced gastric cancer: its association with liver metastasis [Ｊ]. Int J Colorectal Dis， 2003； 18(2)∶160.
